+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hemostaseologic and hematologic parameters with aspirin and ticlopidine treatment in patients with cerebrovascular disease: a cross-over study

Hemostaseologic and hematologic parameters with aspirin and ticlopidine treatment in patients with cerebrovascular disease: a cross-over study

Journal of Cardiovascular Pharmacology 28(4): 591-594

No direct comparisons of the effects of ticlopidine and aspirin on platelet aggregability, clotting parameters, and blood count are available in a cross-over study design in humans. We investigated 45 patients with cerebrovascular disease. Twenty-one patients received 300 mg aspirin once daily for 2 weeks and then for 2 more weeks received 250 mg ticlopidine twice daily. In 24 other patients, the scheme was reversed. ADP-induced aggregability was lower during ticlopidine treatment; epinephrine- and collagen-induced aggregabilities were lower with aspirin treatment. Platelet counts were higher during ticlopidine than during aspirin treatment (199.6/ nl with aspirin, 213.0/nl with ticlop dine, p = 0.008), probably reflecting less platelet activation and degradation and a longer platelet survival time induced by ticlopidine treatment.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 008763521

Download citation: RISBibTeXText

PMID: 8891887

Related references

Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study. Stroke 24(10): 1452-1457, 1993

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. New England Journal of Medicine 321(8): 501-507, 1989

Asymptomatic circulating cerebral emboli and cerebral blood flow velocity under aspirin and ticlopidine in patients with cerebrovascular disease. Neurological Research 18(5): 449-453, 1996

Ticlopidine versus aspirin for stroke prevention: On-treatment results from the ticlopidine aspirin stroke study. Journal of Stroke and Cerebrovascular Diseases 3(3): 168-176, 1993

Ticlopidine versus aspirin for the prevention of recurrent stroke. Analysis of patients with minor stroke from the Ticlopidine Aspirin Stroke Study. Stroke 23(12): 1723-1727, 1992

The efficacy and safety of ticlopidine and aspirin in non-whites: analysis of a patient subgroup from the Ticlopidine Aspirin Stroke Study. Neurology 43(1): 27-31, 1993

Effects of ticlopidine or ticlopidine plus aspirin on platelet aggregation and ATP release in normal volunteers: why aspirin improves ticlopidine antiplatelet activity. Clinical and Applied Thrombosis/Hemostasis 5(4): 243-246, 1999

Comparison of ticlopidine and aspirin versus clopidogrel and aspirin after percutaneous coronary interventions in high-risk patients - A double-blind randomized study. HeartDrug 5(4): 187-192, 2005

The "trials" of a long-term clinical trial: the Ticlopidine Aspirin Stroke Study and the Canadian-American Ticlopidine Study. Controlled Clinical Trials 10(4 Suppl.): 236s-244s, 1989

A double-blind randomised comparison of combined ticlopidine and aspirin therapy vs ticlopidine or aspirin alone on experimental arterial thrombogenesis in man. Circulation 96(8 Suppl. ): I722, 10/21/97, 1997

A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans. Blood 92(5): 1518-1525, 1998

Efficacy and safety of ticlopidine alone vs ticlopidine and aspirin in post-stenting medical treatment Results of a randomized clinical trial. Circulation 96(8 Suppl. ): I593-I594, 10/21/97, 1997

Efficacy and safety of ticlopidine monotherapy versus ticlopidine and aspirin after coronary artery stenting: follow-up results of a randomized study. Journal of Invasive Cardiology 13(6): 431-436, 2001

Effects of long-term ticlopidine treatment on platelet function and its tolerability in cerebrovascular disease. Journal of International Medical Research 12(5): 286-291, 1984

Effect of aspirin on prevention of coronary and cerebrovascular disease in patients with rheumatoid arthritis. A long-term follow-up study. Mayo Clinic Proceedings 53(9): 581-586, 1978